2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.
The challenges faced by globalisation are evolving in real time. For those concentrating on Asia-Pacific, here are the top three worth-noting development.
China’s political landscape is complex. In this article, we take a close look at its intricate political environment, the importance of strategic insight, and what businesses can do to engage in the policy-shaping process.
AI is transforming healthcare. We delve into the variety of ongoing and anticipated applications for AI in healthcare and the approaches that key markets are taking for regulation, also highlighting AI’s application towards challenging therapeutic areas.
COP28 has arrived at the significant midpoint between the 2015 Paris Agreement (COP21) and 2030. Will the conclusions of the Global Stocktake accelerate climate action?
As society becomes more aware of issues related to gender, diversity, equity and inclusion (DEI), there is a growing need to use more inclusive language.
The COVID-19 pandemic has shone a spotlight on the social determinants of health. In recognition of World Health Day 2022 tomorrow, we ask the question - "Is it time for healthcare organisations to drive social impact?"
Sandpiper Healthcare Tracker – health as a priority and its impact on comms 7 March 2022 Great Healthcare Expectations of the Asia Pacific Public Since the […]